KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,492,038 | -10.4% | 50,222 | +14.9% | 0.01% | 0.0% |
Q2 2023 | $9,477,646 | +6.1% | 43,706 | -11.1% | 0.01% | 0.0% |
Q1 2023 | $8,933,963 | -2.6% | 49,185 | +4.3% | 0.01% | -16.7% |
Q4 2022 | $9,176,921 | -9.1% | 47,142 | +4.9% | 0.01% | -14.3% |
Q3 2022 | $10,094,465 | +151.3% | 44,944 | +40.4% | 0.01% | +133.3% |
Q2 2022 | $4,016,360 | +5.7% | 32,006 | +4.5% | 0.00% | +50.0% |
Q1 2022 | $3,800,424 | +156.4% | 30,614 | +169.4% | 0.00% | +100.0% |
Q4 2021 | $1,482,000 | +5.6% | 11,363 | -1.0% | 0.00% | 0.0% |
Q3 2021 | $1,404,000 | -2.6% | 11,480 | -9.3% | 0.00% | 0.0% |
Q2 2021 | $1,442,000 | +30.9% | 12,654 | +38.0% | 0.00% | 0.0% |
Q1 2021 | $1,102,000 | +11.7% | 9,169 | -5.6% | 0.00% | 0.0% |
Q4 2020 | $987,000 | +35.4% | 9,712 | +3.0% | 0.00% | 0.0% |
Q3 2020 | $729,000 | -27.2% | 9,431 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,002,000 | +106.2% | 9,431 | +39.7% | 0.00% | 0.0% |
Q1 2020 | $486,000 | – | 6,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |